{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-039000","form_type":"8-K","ticker":"TNXP","cik":"0001430306","company_name":"Tonix Pharmaceuticals Holding Corp.","filed_at":"2026-08-18T20:00:17+00:00","discovered_at":"2026-08-18T20:01:33.648794+00:00","generated_at":"2026-08-18T20:01:51.207659+00:00","sec_items":["5.02","8.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Tonix appoints CEO Seth Lederman as Interim Chief Medical Officer","bullets":["On Aug 18, 2026, Tonix appointed Dr. Seth Lederman, age 69, as Interim Chief Medical Officer.","Lederman remains President, CEO, and Chairman; no changes to those roles.","No arrangements or family relationships noted in the appointment.","Appointment effective immediately; no compensation changes disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-039000","json":"https://secwatch.observer/filing/0001493152-26-039000.json","markdown":"https://secwatch.observer/filing/0001493152-26-039000.md","text":"https://secwatch.observer/filing/0001493152-26-039000.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226039000/0001493152-26-039000-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1430306/000149315226039000/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T20:01:51.207659+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}